Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Point of Care Diagnostics (POCD) Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Point of Care Diagnostics (POCD) industry at home and abroad, estimate the overall market scale of the Point of Care Diagnostics (POCD) industry and the market share of major countries, Point of Care Diagnostics (POCD) industry, and study and judge the downstream market demand of Point of Care Diagnostics (POCD) through systematic research, Analyze the competition pattern of Point of Care Diagnostics (POCD), so as to help solve the pain points of various stakeholders in Point of Care Diagnostics (POCD) industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Point of Care Diagnostics (POCD) Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Point of Care Diagnostics (POCD) Market?
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Major Type of Point of Care Diagnostics (POCD) Covered in XYZResearch report:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Application Segments Covered in XYZResearch Market
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
For any other requirements, please feel free to contact us and we will provide you customized report.
Summary:
Get latest Market Research Reports on Point of Care Diagnostics (POCD). Industry analysis & Market Report on Point of Care Diagnostics (POCD) is a syndicated market report, published as (Post-pandemic Era)-Global Point of Care Diagnostics (POCD) Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Point of Care Diagnostics (POCD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.